Skip to content
  • Home
  • IOncology
  • Infectious Desease Frontier
  • IHepatology
  • Hematology Frontier
  • Conference topics
  • Experts Interviews
  • Informations
  • Live Broadcasting
  • Logout
MediaMedic

Connecting Medical Expertise through Media

  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations
  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations

Conference topics

Home » Conference topics
  • Dr. Xiaofan Zhu’s Four Study of Rare and Refractory Pediatric Hematologic Diseases  at 2023 EHA

    2023.10.12
  • Dr. Liu Hongxing and Wang Tong: Decoding Structural Aberrations of the PAX5 Gene in B-ALL and its Correlation with Diagnostic Classification and Treatment Outcomes

    2023.10.12
  • Dr. Jie Jin:  the New JAK Inhibitor Jaktinib in the Treatment of Myelofibrosis (MF)

    2023.10.12
  • Dr.  HuilaiZhang’s Team: Key Research in the Field of Hodgkin Lymphoma

    2023.10.12
  • Dr. Huaqing Wang: Primary Mediastinal B-Cell Lymphoma (PMBCL) Benefits More Significantly from Axi-Cel Treatment

    2023.10.12
  • Dr. Hui Wang: A Simple and Rapid Multi-Parameter Flow Cytometry Approach for the Diagnosis and Screening of Malignant Tumors and Related Diseases

    2023.10.12
  • Dr. Daobin Zhou’s Team: Zanubrutinib combined with R-CHOP regimen demonstrates efficacy and safety in primary treatment of Intravascular Large B-Cell Lymphoma

    2023.10.12
  • Dr. Xiaoting Hua: Groundbreaking Findings on Cefiderocol Resistance in Acinetobacter baumannii 丨ECCMID 2023

    2023.10.12
  • Dr. Yimin Wang: Advances in Ventilator-Associated Pneumonia Research丨ECCMID 2023

    2023.10.12
«previous next»
Recent Posts
  • Professor Dingwei Ye: Building an Authoritative Academic Platform in Uro-Oncology and Driving Continuous Progress in Urothelial Carcinoma Management |
  • Professor Hao Zeng’s Team Publishes in JAMA Oncology: Innovative First-Line Immunotherapy Approach for Advanced FH-Deficient Renal Cell Carcinoma
  • AI-Driven Imaging Breakthrough in CAR-T Therapy丨Professor Stephen Schuster on Predicting Efficacy
  • Polatuzumab Improves Survival in Relapsed/Refractory DLBCL丨Phase III POLARGO Study Highlights
  • Breakthrough Discovery of LymphoMAPs in Large B-cell Lymphoma丨Professor David Russler-Germain on CAR T Therapy
Recent Comments
    Archives
    • September 2025
    • August 2025
    • July 2025
    • June 2025
    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • October 2024
    • September 2024
    • August 2024
    • July 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • January 2024
    • December 2023
    • November 2023
    • October 2023
    • August 2023
    Categories
    • Artificial intelligence
    • Hematology Frontier
    • Infectious Disease Frontier
    • International Hepatology
    • IOncology
    • Live broadcasting
    • Uncategorized
    • UroStream
    • LinkedIn
    • Twitter
    • Mail
    Related Media:
    Copyright 2025 — MediaMedic. All rights reserved. Blogun WordPress Theme
    Media Medic Publishing Company Limited(HK)
    赛美出版有限公司(香港)
    Scroll to Top